Neovastat (AE-941) : Aeterna : Angiogenesis inhibitor

NCI-Sponsored Trial Tests Shark Cartilage Extract in Patients with NSCLC (National Cancer Institute)
Announces a large NCI randomized clinical trial to test the effects of shark cartilage (Neovastat or AE-941) in combination with chemotherapy and radiotherapy in patients with NSCLC that cannot be removed by surgery. Describes the trial, and discusses Neovastat and the results of previous studies. [5/01]

Neovastat: Product Sheet (Aeterna Zentaris)
Manufacturer's information on Neovastat, including a description of the drug and how it works. Briefly discusses early trial results. (nb, Corporate summary intended for investors, not patients.) PDF file. [1/06]

Neovastat (AE-941) - Recent MEDLINE Abstracts (PubMed)

Neovastat (AE-941) Clinical Trials (ClinicalTrials.gov)